Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
NHS, Alzheimer
Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare the new treatment for the disease safe for use but the rationing body for the health service will immediately rule that it is too expensive for NHS patients.
'Best ever' Alzheimer's drug 'set to be blocked for NHS use' due to cost pressures
An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by pharmaceutical giant Eli Lilly, is a targeted antibody drug which slows down the early stages of Alzheimer's.
UK's NHS to block Eli Lilly's Alzheimer's drug on Wednesday, Telegraph reports
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too expensive for NHS patients, the Telegraph reported on Tuesday. British regulators are expected to declare the drug safe for use on Wednesday,
Alzheimer's 'wonder' drug will be blocked by NHS from TODAY
Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per cent
Hosted on MSN
14m
Frontotemporal dementia: Not as well known as Alzheimer's disease but still deadly
Because of the confluence of those symptoms, various medical sources note FTD can be misdiagnosed as a mental health disorder, depression, or early onset
Alzheimer
's. Diagnosis often doesn't occur ...
20m
Alzheimer's study in Seattle makes new findings for future therapies
In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...
5h
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...
NOLA.com
1d
Posterial Cortical Atrophy could be wake-up call about future development of Alzheimer's
Posterial Cortical Atrophy, sometimes called Benson’s disease, is a rare degenerative brain condition that affects the back ...
1d
Study detects early Alzheimer's 'stealth' phase before symptoms set in
A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...
FOX 47
11h
UW-Madison leads nationwide study into causes of Alzheimer's, dementia in communities
MADISON, Wis.- A groundbreaking national study into the causes of Alzheimer’s and dementia has begun, led by researchers at ...
Psychology Today
2d
Early Signs of Alzheimer’s Disease? Follow the Money
As our family members age, we worry. We worry about their physical health and potential cognitive declines. If you are ...
WXXI
10h
Jolene Brackey, author of “Creating Moments of Joy Along the Alzheimer’s Journey”
In the second hour of "Connections with Evan Dawson" on Oct. 22, 2024, our guests discuss caregiving for people with ...
Troy Record
19h
RPI gets grants for Alzheimer’s research
Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...
News Medical on MSN
12h
Bilingualism may maintain protection against Alzheimer's, neuroimaging study finds
Bilingualism has long been known to have cognitive benefits for older adults. Research shows it helps delay the onset of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
NHS
National Health Service
Feedback